HealthLynked Corp.
Income Statement
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $249.8K | $423.5K | $310.2K | $388.5K | $592.4K | $774.2K | $618.9K | $590.1K |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| Gross Margin | — | — | — | — | — | — | — | — |
| Operating Expenses | ||||||||
| Research & Development | — | — | — | — | — | — | — | — |
| SG&A Expense | $517.5K | $847.3K | $453.6K | $500.7K | $451.8K | $629.4K | $546.2K | $631.8K |
| Operating Income | $-538.8K | $-700.8K | $-530.9K | $-529.6K | $-435.4K | $-617.4K | $-748.8K | $-1.7M |
| Operating Margin | -215.7% | -165.5% | -171.2% | -136.3% | -73.5% | -79.7% | -121.0% | -283.2% |
| Interest Expense | — | — | — | — | — | — | — | — |
| Pretax Income | — | — | — | — | — | — | $-1.2M | $-2.0M |
| Income Tax Expense | — | — | — | — | — | — | — | — |
| Net Income | $-819.7K | $-1.6M | $-676.5K | $-851.8K | $-701.0K | $-1.1M | $-1.2M | $-2.0M |
| Net Margin | -328.1% | -382.9% | -218.1% | -219.2% | -118.3% | -135.7% | -198.8% | -334.4% |
| EPS (Basic) | $-0.28 | $-0.56 | $-0.24 | $-0.30 | $-0.25 | $-0.37 | $-1.47 | $-0.70 |
| EPS (Diluted) | $-0.28 | $-0.56 | $-0.24 | $-0.30 | $-0.25 | $-0.37 | $-1.47 | $-0.70 |
| Shares Outstanding (Basic) | 2.9M | 2.9M | 2.8M | 2.8M | 2.8M | 2.8M | 2.8M | 2.8M |
| Shares Outstanding (Diluted) | 2.9M | 2.9M | 2.8M | 2.8M | 2.8M | 2.8M | 2.8M | 2.8M |
| Dividends Per Share | — | — | — | — | — | — | — | — |